REGULATORY
8 Members of PAFSC’s Pharmaceutical Affairs Council to Be Ousted for Violating COI Rules
The Ministry of Health, Labor and Welfare (MHLW) announced on June 5 that eight members of the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Pharmaceutical Affairs Council (PAC) will be removed due to their violations of the PAC’s conflicts of…
To read the full story
Related Article
- 8 Members Exit Pharmaceutical Affairs Council
June 26, 2015
REGULATORY
- Unpacking “MFN”: Japan Listed as Reference Country in US Pricing Models
April 16, 2026
- MHLW to Set Criteria for Exemptions under OTC-Like Drug Charge Scheme
April 16, 2026
- MHLW Taps Kawabata to Lead Drug Discovery Support Office
April 15, 2026
- MHLW Reviewing EMIS Data on Petro-Product Supply to Medical Institutions
April 15, 2026
- Japan Panel to Review Ferring Gene Therapy, Fujifilm Cell Product on April 20
April 14, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





